_________
false
à÷ñ èé àì áéåôøîñåèé÷ìñ áò"î
2
381
X T L BIOPHARMACEUTICALS LTD
Corporation no:
520039470
4313
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
10/07/2017
www.isa.gov.il
www.tase.co.il
Reference:
2017-02-072084
Time of broadcast:
14:03
14:01:38
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
On July 9, 2017, the three-year term of Gil Oren, an external director of Can-Fite Biopharma Ltd. (the “Company”) and member of the audit committee and compensation committee of the Company, automatically expired. Mr. Oren may not be re-elected to serve as an external director for an additional term as he was elected for the maximum number of terms permitted under the Israeli Companies Law. As previously reported, on July 25, 2017, the Company plans to hold its 2017 Annual General Meeting of Shareholders, at which meeting, among other things, Yaacov Goldman, is standing for election to replace Mr. Oren as an external director and as a member of the Company’s audit committee and compensation committee.
f6k071017_canfitebiopharmaEDGAR1_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
28/06/2017
Address:
HaCharoshet st
5
,
Ra'anana
43656
Israel
,
Tel:
09-9557080
,
Fax:
09-9519708
E-mail address:
ir@xtlbio.com
Company site:
www.xtlbio.com
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Name of the Signatory:
Kntor Ronen
Position of Signatory in the reporting corporation:
Attorney/Legal Counsel
Name of Employer Company:
Address:
abba hillel
12
,
ramat gan
5250606
Telephone:
03-6133371
Facsimile:
03-6133372
E-mail:
rkantor@dtkgc.com
1